| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 59.7423 | 64 |
| GSM780708 | Untreated after 4 days (C2_1) | 58.9858 | 64 |
| GSM780709 | Untreated after 4 days (C3_1) | 59.9904 | 64 |
| GSM780719 | Untreated after 4 days (C1_2) | 60.2838 | 65 |
| GSM780720 | Untreated after 4 days (C2_2) | 58.6389 | 63 |
| GSM780721 | Untreated after 4 days (C3_2) | 62.3931 | 66 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 62.143 | 66 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 54.5993 | 59 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 60.7269 | 65 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 63.0822 | 66 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 53.4751 | 57 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 60.3132 | 65 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 58.3739 | 63 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 61.9841 | 66 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 58.7162 | 63 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 54.075 | 58 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 56.5427 | 61 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 69.0286 | 69 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 65.8327 | 67 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 62.9064 | 66 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 55.2463 | 60 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 64.6972 | 67 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 57.8919 | 63 |